Spontaneous remission in a patient with therapy-related myelodysplastic syndrome (t-MDS) with monosomy 7

35Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We describe a case of spontaneously reversible refractory anaemia, a subtype of myelodysplastic syndrome (MDS), with monosomy 7 secondary to chronic treatment with azathioprine (AZA) in a young renal transplant recipient. AZA was stopped after that conventional cytogenetics and fluorescence in situ hybridization (FISH) had demonstrated the existence of a monosomy 7 clone. 4 months later, haematological values had considerably improved and the karyotypic examination as well as the FISH analysis were normal. The spontaneous remission of this MDS with monosomy 7, which is usually associated with a particularly poor prognosis. could be due to the recovery of a better immunosurveillance following the withdrawal of AZA.

Cite

CITATION STYLE

APA

Renneboog, R., Hansen, V., Heimann, F., De Mulder, A., Janssen, F., & Ferster, A. (1996). Spontaneous remission in a patient with therapy-related myelodysplastic syndrome (t-MDS) with monosomy 7. British Journal of Haematology, 92(3), 696–698. https://doi.org/10.1046/j.1365-2141.1996.00400.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free